Activation of the “Splenocardiac Axis” by electronic and tobacco cigarettes in otherwise healthy young adults

Physiological Reports

Volumn 5, Issue 17, 2017, Pages

  Boas, Zachary ^a   Gupta, Pawan ^a   Moheimani, Roya S ^a   Bhetraratana, May ^b   Yin, Fen ^b   Peters, Kacey M ^a   Gornbein, Jeffrey ^a   Araujo, Jesus A ^a,b   Czernin, Johannes ^a   Middlekauff, Holly R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arterial inflammation; Electronic cigarettes; FDG PET CT; Hematopoietic activation; Tobacco cigarettes

Indexed keywords

4 NITROPHENOL; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; CIGARETTE SMOKE; COTININE; FLUORODEOXYGLUCOSE F 18; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RADIOPHARMACEUTICAL AGENT;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ELECTRONIC CIGARETTE; ENZYME ACTIVITY; FEMALE; HEART RATE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACTIVITY ASSAY; NERVE STIMULATION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; RADIOACTIVITY; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SMOKING; SPLENOCARDIAC AXIS; SYSTOLIC BLOOD PRESSURE; AORTA; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; HEART; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; SPLEEN;

ADULT; AORTA; CASE-CONTROL STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MALE; MUSCLE, SKELETAL; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SMOKING; SPLEEN;

EID: 85029452571     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.13393     Document Type: Article

References (30)

1. SRNT Subcommittee on Biochemical Verification. 2002. Biochemical verification of tobacco use and cessation. 4:149-159.
2. Breton, C. V., F. Yin, X. Wang, E. Avol, F. D. Gilliland, and J. A. Araujo. 2014. HDL anti-oxidant function associates with LDL level in young adults. Atherosclerosis 232:165-170.
3. Bucerius, J., V. Mani, C. Moncrieff, J. Machac, V. Fuster, M. E. Farkouh, et al. 2014. Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur. J. Nucl. Med. Mol. Imaging 41:369-383.
4. Chen, W., and V. Dilsizian. 2015. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR? J. Nucl. Med. 56:503-504.
5. Connor Gorber, S., S. Schofield-Hurwitz, J. Hardt, G. Levasseur, and M. Tremblay. 2009. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob. Res. 11:12-24.
6. Dutta, P., G. Courties, Y. Wei, F. Leuschner, R. Gorbatov, C. S. Robbins, et al. 2012. Myocardial infarction accelerates atherosclerosis. Nature 487:325-329.
7. Emami, H., and A. Tawakol. 2014. Noninvasive imaging of arterial inflammation using FDG-PET/CT. Curr. Opin. Lipidol. 25:431-437.
8. Emami, H., P. Singh, M. MacNabb, E. Vucic, Z. Lavender, J. H. Rudd, et al. 2015. Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. JACC Cardiovasc. Imaging 8:121-130.
9. Goniewicz, M. L., J. Knysak, M. Gawron, L. Kosmider, A. Sobczak, J. Kurek, et al. 2014. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tobacco Control 23:133-139.
10. Goniewicz, M. L., M. Gawron, D. M. Smith, M. Peng, P. Jacob, and N. L. Benowitz. 2017. Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study. Nicotine Tob. Res. 19:160-167.
11. Grassi, G., G. Seravalle, and G. Mancia. 2015. Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications. Eur. J. Clin. Invest. 45:1367-1375.
12. Haass, M., and W. Kubler. 1997. Nicotine and sympathetic neurotransmission. Cardiovasc. Drugs Ther. 10:657-665.
13. Harte, C. B., and C. M. Meston. 2014. Effects of smoking cessation on heart rate variability among long-term male smokers. Int. J. Behav. Med. 21:302-309.
14. Heidt, T., H. B. Sager, G. Courties, P. Dutta, Y. Iwamoto, A. Zaltsman, et al. 2014. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20:754-758.
15. Higuchi, T., F. Omata, K. Tsuchihashi, K. Higashioka, R. Koyamada, and S. Okada. 2016. Current cigarette smoking is a reversible cause of elevated white blood cell count: crosssectional and longitudinal studies. Prev. Med. Rep. 4:417-422.
16. Huet, P., S. Burg, D. Le Guludec, F. Hyafil, and I. Buvat. 2015. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement. J. Nucl. Med. 56:552-559.
17. Laukova, M., P. Vargovic, L. Csaderova, L. Chovanova, M. Vlcek, R. Imrich, et al. 2012. Acute stress differently modulates beta1, beta2 and beta3 adrenoceptors in T cells, but not in B cells, from the rat spleen. NeuroImmunoModulation 19:69-78.
18. Libby, P., M. Nahrendorf, and F. K. Swirski. 2016. Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: an Expanded “Cardiovascular Continuum”. J. Am. Coll. Cardiol. 67:1091-1103.
19. Middlekauff, H. R., J. Park, and R. S. Moheimani. 2014. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J. Am. Coll. Cardiol. 64:1740-1750.
20. Moheimani, R. S., M. Bhetraratana, F. Yin, K. M. Peters, J. Gornbein, J. A. Araujo, et al. 2017. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2:278-284.
21. Ramanathan, G., J. A. Araujo, J. Gornbein, F. Yin, and H. R. Middlekauff. 2014. Cigarette smoking is associated with dose-dependent adverse effects on paraoxonase activity and fibrinogen in young women. Inhalation Toxicol. 26:861-865.
22. Rosengren, A., S. Hawken, S. Ounpuu, K. Sliwa, M. Zubaid,W. A. Almahmeed, et al., Investigators I. 2004. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364:953-962.
23. Sandhu, R. K., M. C. Jimenez, S. E. Chiuve, K. C. Fitzgerald, S. A. Kenfield, U. B. Tedrow, et al. 2012. Smoking, smoking cessation, and risk of sudden cardiac death in women. Circ. Arrhythm. Electrophysiol. 5:1091-1097.
24. Sarkar, P. D., T., MS, T., MS, and B., Madhusudhan. 2006. Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease. Clin. Chim. Acta 373:77-81.
25. Tarkin, J. M., F. R. Joshi, and J. H. Rudd. 2014. PET imaging of inflammation in atherosclerosis. Nat. Rev. Cardiol. 11:443-457.
26. Tawakol, A., Z. A. Fayad, R. Mogg, A. Alon, M. T. Klimas, H. Dansky, et al. 2013. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. J. Am. Coll. Cardiol. 62:909-917.
27. Thun, M. J., B. D. Carter, D. Feskanich, N. D. Freedman, R. Prentice, A. D. Lopez, et al. 2013. 50-year trends in smoking-related mortality in the United States. N. Engl. J. Med. 368:351-364.
28. Thune, J. J., J. E. Signorovitch, L. Kober, J. J. McMurray, K. Swedberg, J. Rouleau, et al. 2011. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. Eur. J. Heart Fail. 13:148-153.
29. Watson, A. D., J. A. Berliner, S. Y. Hama, B. N. Du La, K. F. Faull, A. M. Fogelman, et al. 1995. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Investig. 96:2882-2891.
30. Yin, F., A. Lawal, J. Ricks, J. R. Fox, T. Larson, M. Navab, et al. 2013. Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional pro-oxidant and pro-inflammatory high-density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 33:1153-1161.